News

Gladstone in the News March 23, 2026

Decoding the Tumor: Inside the AI-Driven Hunt for Colorectal Cancer Immunotherapy

Cancer Research Institute—Colorectal cancer is the second leading cause of cancer-related death in the U.S. But despite decades of progress, immunotherapy still falls short for the vast majority of patients with this cancer. Gladstone Investigator Karin Pelka is working to change that by listening in on the molecular conversations happening inside the tumor itself.

Gladstone Experts Cancer Genomic Immunology Pelka Lab

Gladstone in the News March 18, 2026

Scientists Create Cancer-Fighting Immune Cells Right in the Body

UCSF News—Gladstone Affiliate Investigator Justin Eyquem and his collaborators at Gladstone and UCSF demonstrated a new method to engineer CAR T cells directly inside the body, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

Gladstone Experts Cancer Genomic Immunology Eyquem Lab

Article February 18, 2026

Meet Gladstone: Alisa Dietl

Alisa Dietl brings her international training and clinical perspective to Gladstone, where she works to engineer more effective cancer immunotherapies for solid tumors.

Graduate Students and Postdocs Profile Cancer Pelka Lab

Article November 13, 2025

Researchers Reveal Intricate Control System for Key Immune Gene

Scientists learn to fine-tune a gene that is centrally involved in regulating the immune system, offering potential clues for future autoimmunity and cancer treatments.

News Release Research (Publication) Autoimmune Diseases Cancer Genomic Immunology Marson Lab

Article October 28, 2025

Rewriting Cellular Instructions to Make Better Tumor-Fighting Immunotherapies

A powerful scientific platform opens new possibilities for treating cancer, autoimmune diseases, and other conditions in which reprogrammed T cells could provide a benefit to patients.

News Release Research (Publication) Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing

Gladstone in the News October 23, 2025

Epigenetic Reprogramming Platform Offers Path to More Effective T Cell Therapies

Inside Precision Medicine—A scientific tool developed by Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and his collaborators opens new possibilities for treating cancer, autoimmune diseases, and other conditions.

Gladstone Experts Autoimmune Diseases Cancer Genomic Immunology Marson Lab

Gladstone in the News October 6, 2025

Nobel Prize in Physiology or Medicine Is Awarded for Work on Immune Systems

The New York Times—After scientists were awarded the 2025 Nobel Prize in Physiology or Medicine for their discoveries of peripheral immune tolerance, Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, comments on how their work has been central to understanding autoimmune diseases and cancers. (Subscription required.)

Gladstone Experts Autoimmune Diseases Cancer Genomic Immunology Marson Lab

Article September 25, 2025

Beyond Viruses: Expanding the Fight Against Infectious Diseases

The newly renamed Gladstone Infectious Disease Institute broadens its mission to address global health threats ranging from antibiotic resistance to infections that cause chronic diseases.

Institutional News News Release Cancer COVID-19 Hepatitis C HIV/AIDS Zika Virus Infectious Disease

Article September 2, 2025

Virologist Viewpoints: The Promise of Cancer Vaccines

Magnus Hoffmann explains the science behind cancer vaccines and how they could change the game.

Gladstone Experts Cancer Infectious Disease

Gladstone in the News August 14, 2025

With Vaccine Research Under Attack, It’s Time for California to Lead Again

The San Francisco Standard—In this opinion piece, Melanie Ott, director of the Gladstone Institute of Virology, writes that halting mRNA research right now is like banning ChatGPT—it's not just scientific negligence, but strategic self-sabotage. She proposes ways for California to take the lead by funding crucial research at the state level.

Gladstone Experts Cancer COVID-19 HIV/AIDS Infectious Disease Ott Lab

Gladstone in the News June 23, 2025

5 Ways AI is Changing the Landscape of Cancer Research and Immunotherapy

Cancer Research Institute—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, helps explain how AI will transform the future of cancer treatment and how scientists are shaping the next wave of progress in cancer immunotherapy.

Gladstone Experts Cancer Genomic Immunology Marson Lab

Gladstone in the News June 17, 2025

Wachtel Award Recipient Identifies Immune Hubs to Improve Cancer Therapy

AAAS—Gladstone Investigator Karin Pelka is selected as the 2025 recipient of the AAAS Martin and Rose Wachtel Cancer Research Award for her work in identifying some of the critical multicellular interaction networks in the body’s fight against cancer.

Awards Cancer Pelka Lab

Article June 11, 2025

Ask a Scientist: When Will Immunotherapy Work on Common Cancers?

For Cancer Immunotherapy Month, Karin Pelka answers questions about how immunotherapy can treat patients with solid tumors and the challenges that scientists are working to overcome.

Gladstone Experts Cancer Genomic Immunology Data Science and Biotechnology Pelka Lab

Article May 7, 2025

Karin Pelka Wins Grant to Advance Immunotherapy for Colorectal Cancer

The Colorectal Cancer Alliance has awarded Pelka a $500,000 grant to develop novel immunotherapies that overcome the most common form of colorectal cancer.

Grants News Release Cancer Pelka Lab

Article January 21, 2025

Seeing the Unseen: New Method Reveals ’Hyperaccessible’ Window in Freshly Replicated DNA

A Gladstone team has unearthed new findings about what happens during the minutes and hours after a cell divides, expanding our understanding of human biology—and potentially leading to better medicines.

News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab